EI
EAM Investors Portfolio holdings
AUM
$660M
1-Year Return
271.72%
This Quarter Return
+25.32%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,914.37%
AUM
$615M
AUM Growth
-$26.4M
(-4.1%)
Cap. Flow
-$52M
Cap. Flow
% of AUM
-8.46%
Top 10 Holdings %
Top 10 Hldgs %
10.02%
Holding
357
New
126
Increased
9
Reduced
90
Closed
116
Top Buys
| 1 |
Insmed
INSM
|
+$7.22M |
| 2 |
FTAI Aviation
FTAI
|
+$7.04M |
| 3 |
Transmedics
TMDX
|
+$5.19M |
| 4 |
FormFactor
FORM
|
+$5.15M |
| 5 |
Brink's
BCO
|
+$4.77M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
+$5.99M |
| 2 |
Applied Industrial Technologies
AIT
|
+$5.91M |
| 3 |
Nextracker
NXT
|
+$5.79M |
| 4 |
Aaon
AAON
|
+$5.52M |
| 5 |
Leonardo DRS
DRS
|
+$5.36M |
Sector Composition
| 1 | Industrials | 26.41% |
| 2 | Technology | 22.84% |
| 3 | Healthcare | 18.28% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Apogee Therapeutics
APGE
$2.23B
| – | – |
-55,113
| Closed | -$3.66M |
|
252
Applied Therapeutics
APLT
$64M
| – | – |
-92,872
| Closed | -$632K |
|
253
Aquestive Therapeutics
AQST
$599M
| – | – |
-108,244
| Closed | -$461K |
|
254
Archrock
AROC
$4.35B
| – | – |
-203,400
| Closed | -$4M |
|
255
Armstrong World Industries
AWI
$8.61B
| – | – |
-32,820
| Closed | -$4.08M |
|
256
AXT Inc
AXTI
$156M
| – | – |
-200,495
| Closed | -$920K |
|
257
Acuity Brands
AYI
$10.1B
| – | – |
-15,199
| Closed | -$4.08M |
|
|
AZEK
258
DELISTED
The AZEK Co
AZEK
| – | – |
-81,064
| Closed | -$4.07M |
|
259
Bandwidth Inc
BAND
$458M
| – | – |
-56,566
| Closed | -$1.03M |
|
260
Couchbase
BASE
$1.35B
| – | – |
-139,261
| Closed | -$3.66M |
|
261
Biohaven
BHVN
$1.49B
| – | – |
-58,364
| Closed | -$3.19M |
|
262
Backblaze
BLZE
$534M
| – | – |
-106,817
| Closed | -$1.09M |
|
263
Bowman Consulting
BWMN
$703M
| – | – |
-25,463
| Closed | -$886K |
|
264
BWX Technologies
BWXT
$15.5B
| – | – |
-39,869
| Closed | -$4.09M |
|
265
Caleres
CAL
$532M
| – | – |
-93,804
| Closed | -$3.85M |
|
266
Codexis
CDXS
$220M
| – | – |
-199,474
| Closed | -$696K |
|
267
Celldex Therapeutics
CLDX
$1.67B
| – | – |
-70,115
| Closed | -$2.94M |
|
268
Climb Global Solutions
CLMB
$586M
| – | – |
-12,406
| Closed | -$879K |
|
269
Core & Main
CNM
$9.26B
| – | – |
-74,486
| Closed | -$4.26M |
|
270
Collegium Pharmaceutical
COLL
$1.19B
| – | – |
-79,949
| Closed | -$3.1M |
|
271
Cardiff Oncology
CRDF
$138M
| – | – |
-161,903
| Closed | -$865K |
|
272
Cavco Industries
CVCO
$4.28B
| – | – |
-11,050
| Closed | -$4.41M |
|
273
Crexendo
CXDO
$194M
| – | – |
-181,506
| Closed | -$873K |
|
274
CyberArk
CYBR
$23.8B
| – | – |
-5,425
| Closed | -$1.44M |
|
275
Cytokinetics
CYTK
$6.22B
| – | – |
-40,625
| Closed | -$2.85M |
|